Novel Allogeneic Adipose Cell-Based Viral Therapies Clinical Trials Grant Program.

Existing law provides various programs and funding to prevent and mitigate the impacts of cancer and other diseases in this state. Existing law defines the duties of the Treasurer, which include, but are not limited to, keeping an account of all money received and disbursed. This bill would establish, upon appropriation by the Legislature, the Novel Allogeneic Adipose Cell-Based Viral Therapies Clinical Trials Grant Program to provide funding for clinical trials of novel allogeneic adipose cell-based viral therapies for cancer treatment. The program would be administered by the Treasurer, who would be required to award competitive grants to health facilities that meet specific requirements, including providing the Treasurer with specific patient safety data. The bill would require the Treasurer to award a significant amount of grant money to clinical trials conducted in low-income communities, traditionally excluded from leading-edge clinical trials. The bill would require the Treasurer to submit a report to the Legislature on the progress of clinical trials funded pursuant to the program, as specified. This bill would repeal these provisions on January 1, 2031. The bill would make related findings and declarations.